The HEADWIND Study - Part 2

NCT04569630 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
22
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators